PubRank

G Wolberg

Author PubWeight™ 32.01‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Adenosine inhibition of lymphocyte-mediated cytolysis: possible role of cyclic adenosine monophosphate. Science 1975 1.92
2 Mouse virulence of K(L) antigen-containing strains of Escherichia coli. J Bacteriol 1969 1.52
3 Inhibition of lymphocyte-mediated cytolysis by 3-deazaadenosine: evidence for a methylation reaction essential to cytolysis. Proc Natl Acad Sci U S A 1978 1.35
4 2-Fluoroadenosine 3':5'-monophosphate. A metabolite of 2-fluoroadenosine in mouse cytotoxic lymphocytes. J Biol Chem 1976 0.99
5 Chemotactic peptide induces cAMP elevation in human neutrophils by amplification of the adenylate cyclase response to endogenously produced adenosine. J Biol Chem 1989 0.96
6 3-Deazaadenosine-induced disorganization of macrophage microfilaments. Proc Natl Acad Sci U S A 1985 0.94
7 Reversible inhibition of lymphocyte mediated cytolysis by dimethyl sulfoxide (DMSO). J Immunol 1973 0.93
8 Inhibition of lymphocyte-mediated cytolysis by adenosine analogs. Biochemical studies concerning mechanism of action. Biochem Pharmacol 1978 0.92
9 Modulation of cyclic AMP metabolism by S-adenosylhomocysteine and S-3-deazaadenosylhomocysteine in mouse lymphocytes. Proc Natl Acad Sci U S A 1980 0.91
10 Passive hemagglutination. II. Titration of antibody against determinants unique for aggregated denatured bovine serum albumin and further studies on gelatin. J Immunol 1970 0.89
11 Studies on passive hemagglutination. I. Titration of "early" and "late" antibodies with tanned red cells sensitized with native or denatured bovine serum albumin. J Immunol 1969 0.89
12 Antibody to Corynebacterium parvum in normal human and animal sera. Infect Immun 1977 0.89
13 Antagonism by taxol of effects of microtubule-disrupting agents on lymphocyte cAMP metabolism and cell function. Proc Natl Acad Sci U S A 1984 0.83
14 3-deazaadenosine inhibits leukocyte adhesion and ICAM-1 biosynthesis in tumor necrosis factor-stimulated human endothelial cells. J Immunol 1990 0.82
15 Imidazo[4,5-c]pyridines (3-deazapurines) and their nucleosides as immunosuppressive and antiinflammatory agents. J Med Chem 1986 0.82
16 Effects of calmodulin antagonists on immune mouse lymphocytes. Mol Pharmacol 1984 0.81
17 Iron chelates bind nitric oxide and decrease mortality in an experimental model of septic shock. Proc Natl Acad Sci U S A 1996 0.80
18 In vivo and in vitro antitumor activity expressed by cells of concomitantly immune mice. Cancer Res 1983 0.80
19 3-Deazaadenosine 5'-triphosphate: a novel metabolite of 3-deazaadenosine in mouse leukocytes. Biochem Pharmacol 1989 0.80
20 Metabolism of tubercidin and formycin to their 3':5'-cyclic nucleotides in mammalian cells. J Biol Chem 1978 0.80
21 Xenogeneic ICAM-1 gene transfer suppresses tumorigenicity and generates protective antitumor immunity. Gene Ther 1996 0.79
22 Effects of adenosine on neutrophil polarization induced by N-formyl-methionyl-leucyl-phenylalanine, sodium propionate and colchicine. Agents Actions 1989 0.79
23 Ca2+ ionophore-induced cyclic adenosine-3',5'-monophosphate elevation in human neutrophils. A calmodulin-dependent potentiation of adenylate cyclase response to endogenously produced adenosine: comparison to chemotactic agents. Biochem Pharmacol 1991 0.79
24 Inhibition of lymphocyte-mediated cytolysis and cyclic AMP phosphodiesterase by erythro-9-(2-hydroxy-3-nonyl)adenine. J Immunopharmacol 1982 0.78
25 Immunosuppressive effects of the S-adenosylhomocysteine hydrolase inhibitor, 3-deazaadenosine. J Immunopharmacol 1982 0.78
26 Inhibition of lymphocyte-mediated cytolysis by 2-fluoroadenosine--evidence for two discrete mechanisms of drug action. Biochem Pharmacol 1978 0.78
27 Immune reaction of tumor-bearing mice to Propionibacterium acnes and the antitumor effect of the bacteria. Cancer Immunol Immunother 1982 0.78
28 Taxol inhibits N-formyl-methionyl-leucyl-phenylalanine (FMLP)-induced human neutrophil polarization and H2O2 production while decreasing [3H]FMLP binding. Agents Actions 1987 0.77
29 Inhibition of cyclic AMP phosphodiesterase by 5'-deoxy-5'-S-isobutylthioadenosine at biologically active concentrations of drug. Life Sci 1981 0.77
30 Targets of nitric oxide in a mouse model of liver inflammation by Corynebacterium parvum. Arch Biochem Biophys 1995 0.77
31 Metabolic formation of nucleoside-modified analogues of S-adenosylmethionine. Biochem Biophys Res Commun 1979 0.77
32 Potentiation by homocysteine of adenosine-stimulated elevation of cellular adnosine 3',5'-monophosphate. Biochem Pharmacol 1979 0.77
33 3-Deazaadenosine. S-adenosylhomocysteine hydrolase-independent mechanism of action in mouse lymphocytes. J Biol Chem 1984 0.77
34 Inhibition of neutrophil adherence to endothelial cells by 3-deazaadenosine. Agents Actions 1989 0.76
35 Inhibition of lymphocyte cyclic AMP phosphodiesterase and lymphocyte function by 5'-methylthioadenosine. Biochem Pharmacol 1982 0.76
36 Efficacy of treatment with the iron (III) complex of diethylenetriamine pentaacetic acid in mice and primates inoculated with live lethal dose 100 Escherichia coli. J Clin Invest 1996 0.75
37 Adenosine analogues as substrates and inhibitors of S-adenosylhomocysteine hydrolase in intact lymphocytes. Biochemistry 1980 0.75
38 In vitro cytotoxicity expressed by cells active against established tumors in vivo. Cancer Res 1981 0.75
39 Inhibition of lymphocyte function by 9-deazaadenosine. Biochem Pharmacol 1983 0.75
40 Effects of adenosine deaminase inhibitors on lymphocyte-mediated cytolysis. Ann N Y Acad Sci 1985 0.75
41 Effect of acyclovir on various murine in vivo and in vitro immunologic assay systems. Am J Med 1982 0.75
42 Inhibition of immune cell function by adenosine: biochemical studies. Adv Exp Med Biol 1979 0.75